News

More than 100 students from across Cornell campuses and 17 other universities gathered in New York City March 6–8 for the Cornell Health AI Hackathon.

An enigmatic type of circulating tumor cell called a dual-positive cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine. 

Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell Medicine investigators. 

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. 

State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. 

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.

Dr. Ekta Khurana, an associate professor of systems and computational biomedicine at Weill Cornell Medicine, has received a two-year, $1 million Challenge Award from the Prostate Cancer Foundation to work with researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center on an AI-based method for early detection of treatment-resistant prostate tumor subtypes.

Fourteen members of Cornell’s faculty and staff are being recognized this year with Community-Engaged Practice and Innovation Awards from the David M. Einhorn Center for Community Engagement. 

Two Weill Cornell Medicine physician-scientists, Dr. Hooman Kamel and Dr. Robert Peck, have been elected members of the American Society for Clinical Investigation (ASCI) for 2026.  

Awards, honors and achievements for the month of February. 

Dr. Rohan Jotwani, the Nanette Laitman Education Scholar in Entrepreneurship and an assistant professor of clinical anesthesiology at Weill Cornell Medicine, has been selected for the prestigious Macy Faculty Scholars Program. 

A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure. 

Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a preclinical study by Weill Cornell Medicine investigators.

Encompassing a Dean’s Lecture Series and Dean’s Grant Program, the initiative aims to provide the institutional infrastructure and services needed to support AI use safely and effectively among faculty, staff and students.

The WCCHR provides survivors of persecution or torture seeking asylum in the U.S. with objective forensic evaluations, which are psychological and physical assessments, including gynecological exams, that can last up to three hours. Since its inception, the center has evaluated more than 1,100 people.

Dr. Anca Dinu Askanase will serve as chief of the Division of Rheumatology at HSS as well as at Weill Cornell Medicine

The popular diabetes and weight-loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators. The findings may offer comfort to patients concerned about their eye health while taking the drug.

When food is scarce, stress hormones direct the immune system to operate in “low power” mode to preserve immune function while conserving energy, according to researchers at Weill Cornell Medicine.

Two Weill Cornell Medicine physician-scientists, Dr. Semra Etyemez and Dr. Jesse Platt, have been honored with prestigious early-career awards from the American Society for Clinical Investigation (ASCI) for 2026.

Dr. George Coukos, an internationally renowned expert on cancer immunology, is launching the Ludwig Laboratory for Cell Therapy at Weill Cornell Medicine.